Übergewicht verursacht unzählige Folgeerkrankungen, so auch Typ-2-Diabetes.
Gute Nachricht: Abnehmen hilft – je früher, desto besser. So reichen bereits 5-10% Gewichtsabnahme, um Typ-2-Diabetes zu verhindern, aber wenn der Diabetes bereits da ist, müssen es schon mindestens 15% sein, um in eine Remission zu kommen.
Prof. McGowan, UK
#ATTD2025 #Diabetes #dedocVoice #dedoc° #Diabeteskonferenz #NothingAboutUsWithoutUs #Bluthochdruck #PCOS #NAFLD #Reflux #Schlafapnoe #Arthrose
@diabsite
Interpreting Common Cirrhosis Lab Tests
You are wracked with countless tests that you don’t fully understand
https://gayinthecle.com/2025/01/28/common-cirrhosis-tests/
#gay #lesbian #bisexual #transgender #queer #cle #lgbtq #gayinthecle #advice #healthy #cirrhosis #NAFLD #AFLD #liverdisease
"Non-alcoholic fatty liver disease is associated with overactive bladder in women and with benign prostate hyperplasia in men, "Beyond the Abstract," by Hakkı Uzun, MD"
https://www.urotoday.com/recent-abstracts/pelvic-health-reconstruction/overactive-bladder/64994-non-alcoholic-fatty-liver-disease-is-associated-with-overactive-bladder-in-women-and-with-benign-prostate-hyperplasia-in-men-beyond-the-abstract-by-hakk-uzun-md.html
And so?
#Health #HealthCare #NonAlcoholicFattyLiver #Disease #OveractiveBladder #BenignProstateHyperplasia #NAFLD #BPH #OAB
UroToday - GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and urology.
Discover how a ketogenic diet (LCHF) can improve liver health by reducing liver fat by 35.3% in just four days! This study, published in the American Journal of Clinical Nutrition, suggests that reducing carbs and increasing healthy fats might be more effective than conventional low-fat, high-carb diets. Learn more about the study and its implications for managing NAFLD.
Ellagic acid is a polyphenolic, non-flavonoid compound naturally found in a variety of fruits, such as pomegranates, raspberries, strawberries, and grapes, and nuts, such as pistachios, pecans, walnuts, and acorns.
Risks of digestive diseases in #longCOVID: evidence from a population-based cohort study
“we found even in people with mild #COVID19 symptoms who did not receive hospitalization treatment, the risks of GI dysfunction, #PUD, #GERD, & #NAFLD were evident, while the risks of severe liver disease, IBD, & biliopancreatic diseases were not”
@longcovid
#PwLC #LC #postcovid @covid19
#COVID #SARSCoV2 @novid #novid #CovidIsNotOver @auscovid19
Background In the post-pandemic era, a wide range of COVID-19 sequelae is of growing health concern. However, the risks of digestive diseases in long COVID have not been comprehensively understood. To investigate the long-term risk of digestive diseases among COVID patients. Methods In this large-scale retrospective cohort study with up to 2.6 years follow-up (median follow-up: 0.7 years), the COVID-19 group (n = 112,311), the contemporary comparison group (n = 359,671) and the historical comparison group (n = 370,979) predated the COVID-19 outbreak were built using UK Biobank database. Each digestive outcome was defined as the diagnosis 30 days or more after the onset of COVID-19 infection or the index date. Hazard ratios (HRs) and corresponding 95% confidence intervals (CI) were computed utilizing the Cox regression models after inverse probability weighting. Results Compared with the contemporary comparison group, patients with previous COVID-19 infection had higher risks of digestive diseases, including gastrointestinal (GI) dysfunction (HR 1.38 (95% CI 1.26 to 1.51)); peptic ulcer disease (HR 1.23 (1.00 to 1.52)); gastroesophageal reflux disease (GERD) (HR 1.41 (1.30 to 1.53)); gallbladder disease (HR 1.21 (1.06 to 1.38)); severe liver disease (HR 1.35 (1.03 to 1.76)); non-alcoholic liver disease (HR 1.27 (1.09 to 1.47)); and pancreatic disease (HR 1.36 (1.11 to 1.66)). The risks of GERD were increased stepwise with the severity of the acute phase of COVID-19 infection. Even after 1-year follow-up, GERD (HR 1.64 (1.30 to 2.07)) and GI dysfunction (HR 1.35 (1.04 to 1.75)) continued to pose risks to COVID-19 patients. Compared to those with one SARS-CoV-2 infection, reinfected patients were at a higher risk of pancreatic diseases (HR 2.57 (1.23 to 5.38)). The results were consistent when the historical cohort was used as the comparison group. Conclusions Our study provides insights into the association between COVID-19 and the long-term risk of digestive system disorders. COVID-19 patients are at a higher risk of developing digestive diseases. The risks exhibited a stepwise escalation with the severity of COVID-19, were noted in cases of reinfection, and persisted even after 1-year follow-up. This highlights the need to understand the varying risks of digestive outcomes in COVID-19 patients over time, particularly those who experienced reinfection, and develop appropriate follow-up strategies.
What Do My Fibroscan Results Mean – Fatty Liver
Understand your FibroScan Scores For Fatty Liver. Is your fatty liver reversible? #fibroscan #fattyliver #liverhealth #fattylivertreatment #fattyliverdisease #NAFLD #NASH
https://fixfattyliver.com/what-does-my-fibroscan-scores-mean-fatty-liver/
Saskia Wolf 💙
GayintheCLE
John E. Bartley, III (D) K7AAY
notes
The Healthy Pitmaster
Liz Hiles
Matt Willemsen
Tom Kindlon
ConscienHealth
fixfattyliver